Onconetix, Inc. Defined Benefit Plan, Amortization of Gain (Loss)
Onconetix, Inc. (ONCO) reported Defined Benefit Plan, Amortization of Gain (Loss) of $21.85 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses · last filed 2026-03-13
- Onconetix, Inc. defined benefit plan, amortization of gain (loss) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Onconetix, Inc. defined benefit plan, amortization of gain (loss) for the quarter ending 2025-09-30 was $6.72K.
- Onconetix, Inc. defined benefit plan, amortization of gain (loss) for the quarter ending 2024-12-31 was $3.85K.
- Onconetix, Inc. defined benefit plan, amortization of gain (loss) for the quarter ending 2024-09-30 was -$3.69K.
- Onconetix, Inc. defined benefit plan, amortization of gain (loss) for fiscal 2025 was $21.85K, a 42.38% increase from fiscal 2024.
- Onconetix, Inc. defined benefit plan, amortization of gain (loss) for fiscal 2024 was $15.35K.
| Period end | Defined Benefit Plan, Amortization of Gain (Loss) 1 month | Defined Benefit Plan, Amortization of Gain (Loss) 3 month | Defined Benefit Plan, Amortization of Gain (Loss) 6 month | Defined Benefit Plan, Amortization of Gain (Loss) 9 month | Defined Benefit Plan, Amortization of Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $6.72K derived: sum of 2 quarters · filed 2026-03-13 | $21.85K 10-K · filed 2026-03-13 | ||
| 2025-09-30 | $6.72K 10-Q · filed 2025-11-13 | $21.85K 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | $3.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $169.00 derived: sum of 2 quarters · filed 2026-03-13 | -$100.00 derived: sum of 3 quarters · filed 2026-03-13 | $15.35K 10-K · filed 2026-03-13 | |
| 2024-09-30 | -$3.69K 10-Q · filed 2025-11-13 | -$3.96K derived: sum of 2 quarters · filed 2025-11-13 | $11.49K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$269.00 10-Q · filed 2024-08-29 | $15.18K 10-Q · filed 2024-08-29 | |||
| 2024-03-31 | $15.45K 10-Q · filed 2024-05-20 | ||||
| 2023-12-31 | $1.53K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |